Children and young people should routinely be offered the opportunity to participate in and to benefit from medical research.
Children and young people should routinely be offered the opportunity to participate in and to benefit from medical research, according to updated guidance from the UK Royal College of Pediatrics and Child Health.
The guidelines provide updated practical information on ethical issues in relation to research involving children, aimed at research councils. It reflects many of the changes that have taken place with regards to EU regulations over the last 14 years. The key principles include:
“Children require protection, but this should not preclude the claim of other rights, including the right to the highest standard of healthcare, to be informed, express their views, and influence decisions made about them,” said lead author Neena Modi, MD, Professor of Neonatal Medicine at Imperial College London. “The more robust research we can conduct, the greater the likelihood of developing new treatments and procedures that will greatly improve healthcare for children and young people.”
The guidelines also emphasize the importance of involving children, young people and parents in all aspects of medical research—from prioritization to development and dissemination. Overall, they reflect current regulations and should help researchers make the right decisions about child health research in the best interest of the child, she added.
The guidance was published in an online article posted on June 9 by
Archives of Disease in Childhood
. To access the full article,
click here
.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.